ask="N/A"
ask_size="N/A"
average_daily_volume="38590"
bid="2.20"
bid_size="100"
book_value="0.49"
change="-0.01"
change_from_200_day_moving_average="-1.35"
change_from_50_day_moving_average="-0.84"
change_from_52_week_high="-6.71"
change_From_52_week_low="0.23"
change_in_percent="-0.43%"
close="2.29"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.42"
ebitda="-15.65M"
eps_estimate_current_year="-1.73"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="5081000"
high="2.40"
high_52_weeks="9.00"
last_trade_date="2/21/2017"
last_trade_price="2.29"
last_trade_size="390"
last_trade_time="3:59pm"
low="2.26"
low_52_weeks="2.06"
market_capitalization="19.19M"
moving_average_200_day="3.64"
moving_average_50_day="3.13"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="2.33"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-37.01%"
percent_change_from_50_day_moving_average="-26.83%"
percent_change_from_52_week_high="-74.56%"
percent_change_from_52_week_low="+11.17%"
previous_close="2.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.66"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.09"
stock_exchange="NCM"
symbol="VTGN"
volume="41349"
weeks_range_52="2.06 - 9.00"
